160 related articles for article (PubMed ID: 23886504)
41. Development of a cost-effective assay for genotyping of HIV-1 non-B subtype for drug resistance.
Ammaranond P; Sanguansittianant S; Raju PA; Cunningham P; Horthongkham N
J Virol Methods; 2014 Apr; 199():102-7. PubMed ID: 24462843
[TBL] [Abstract][Full Text] [Related]
42. In vitro analysis of the susceptibility of HIV-1 subtype A and CRF01_AE integrases to raltegravir.
Bellecave P; Malato L; Calmels C; Reigadas S; Parissi V; Andreola ML; Fleury H
Int J Antimicrob Agents; 2014 Aug; 44(2):168-72. PubMed ID: 24935032
[TBL] [Abstract][Full Text] [Related]
43. Genotypic/phenotypic patterns of HIV-1 integrase resistance to raltegravir.
Canducci F; Marinozzi MC; Sampaolo M; Boeri E; Spagnuolo V; Gianotti N; Castagna A; Paolucci S; Baldanti F; Lazzarin A; Clementi M
J Antimicrob Chemother; 2010 Mar; 65(3):425-33. PubMed ID: 20056687
[TBL] [Abstract][Full Text] [Related]
44. [Drug-resistance characteristics of CRF01_AE and CRF07_BC subtypes of HIV-1 strains in Sichuan province].
Yuan D; Su L; Liu H; Yu H; Yang H; Ye L; Wei D; Pei X; Liang S
Zhonghua Yu Fang Yi Xue Za Zhi; 2015 Oct; 49(10):901-6. PubMed ID: 26813724
[TBL] [Abstract][Full Text] [Related]
45. [Human immunodeficiency virus type 1 strains epidemic in Shenzhen].
Feng TJ; Zhao GL; Chen L; Wang XH; Shi XD
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2006 Oct; 28(5):637-41. PubMed ID: 17121221
[TBL] [Abstract][Full Text] [Related]
46. Development of an HIV-1 integrase genotyping assay for HIV-1 subtype AE.
Liu Y; Margot N; Kitrinos KM; Callebaut C
J Med Virol; 2019 May; 91(5):890-893. PubMed ID: 30548936
[TBL] [Abstract][Full Text] [Related]
47. Molecular epidemiology of HIV-1 subtypes and drug resistant strains in Taiwan.
Lan YC; Elbeik T; Dileanis J; Ng V; Chen YJ; Leu HS; Cheng SH; Wong JC; Wong WW; Chen YM
J Med Virol; 2008 Feb; 80(2):183-91. PubMed ID: 18098141
[TBL] [Abstract][Full Text] [Related]
48. Determination of the high prevalence of Dual/Mixed- or X4-tropism among HIV type 1 CRF01_AE in Hong Kong by genotyping and phenotyping methods.
To SW; Chen JH; Wong KH; Chan KC; Chen Z; Yam WC
AIDS Res Hum Retroviruses; 2013 Aug; 29(8):1123-8. PubMed ID: 23647565
[TBL] [Abstract][Full Text] [Related]
49. Prevalence of resistance mutations related to integrase inhibitor S/GSK1349572 in HIV-1 subtype B raltegravir-naive and -treated patients.
Malet I; Wirden M; Fourati S; Armenia D; Masquelier B; Fabeni L; Sayon S; Katlama C; Perno CF; Calvez V; Marcelin AG; Ceccherini-Silberstein F
J Antimicrob Chemother; 2011 Jul; 66(7):1481-3. PubMed ID: 21474479
[TBL] [Abstract][Full Text] [Related]
50. Prevalence of the K65R resistance reverse transcriptase mutation in different HIV-1 subtypes in Israel.
Turner D; Shahar E; Katchman E; Kedem E; Matus N; Katzir M; Hassoun G; Pollack S; Kessner R; Wainberg MA; Avidor B
J Med Virol; 2009 Sep; 81(9):1509-12. PubMed ID: 19626612
[TBL] [Abstract][Full Text] [Related]
51. HIV-1 Integrase Resistance among Highly Antiretroviral Experienced Patients from Morocco.
Alaoui N; El Alaoui MA; El Annaz H; Farissi FZ; Alaoui AS; El Fahime E; Mrani S
Intervirology; 2019; 62(2):65-71. PubMed ID: 31307042
[TBL] [Abstract][Full Text] [Related]
52. The lack of epidemiological link between the HIV type 1 infections in Hong Kong and Mainland China.
Lim WL; Xing H; Wong KH; Wong MC; Shao YM; Ng MH; Lee SS
AIDS Res Hum Retroviruses; 2004 Mar; 20(3):259-62. PubMed ID: 15117447
[TBL] [Abstract][Full Text] [Related]
53. Evaluation of NucliSens EasyQ HIV-1 assay for quantification of HIV-1 subtypes prevalent in South-east Asia.
Lam HY; Chen JH; Wong KH; Chan K; Li P; Lee MP; Tsang DN; Yuen KY; Yam WC
J Clin Virol; 2007 Jan; 38(1):39-43. PubMed ID: 17110162
[TBL] [Abstract][Full Text] [Related]
54. Evolution patterns of raltegravir-resistant mutations after integrase inhibitor interruption.
Canducci F; Barda B; Ceresola E; Spagnuolo V; Sampaolo M; Boeri E; Nozza S; Cossarin F; Galli A; Gianotti N; Castagna A; Lazzarin A; Clementi M
Clin Microbiol Infect; 2011 Jun; 17(6):928-34. PubMed ID: 20854427
[TBL] [Abstract][Full Text] [Related]
55. HIV-1 integrase resistance among antiretroviral treatment naive and experienced patients from Northwestern Poland.
Parczewski M; Bander D; Urbańska A; Boroń-Kaczmarska A
BMC Infect Dis; 2012 Dec; 12():368. PubMed ID: 23259737
[TBL] [Abstract][Full Text] [Related]
56. [Feasibility of using dried blood spots to detect HIV drug resistance genotyping].
Ma PF; Xing H; Liao LJ; Chen B; Zhao QB; Quan Y; Sun F; Yang SM; Su B; Chen X; Shao YM
Zhonghua Yu Fang Yi Xue Za Zhi; 2010 Nov; 44(11):993-8. PubMed ID: 21215126
[TBL] [Abstract][Full Text] [Related]
57. Genetic barrier for attachment inhibitor BMS-626529 resistance in HIV-1 B and non-B subtypes.
Fofana DB; Charpentier C; Maïga AI; Lambert-Niclot S; Sayon S; Désiré N; Simon A; Yazdanpanah Y; Katlama C; Descamps D; Calvez V; Marcelin AG; Soulié C
J Antimicrob Chemother; 2015 Jan; 70(1):130-5. PubMed ID: 25270328
[TBL] [Abstract][Full Text] [Related]
58. Structural effects of amino acid variations between B and CRF02-AG HIV-1 integrases.
Malet I; Soulie C; Tchertanov L; Derache A; Amellal B; Traore O; Simon A; Katlama C; Mouscadet JF; Calvez V; Marcelin AG
J Med Virol; 2008 May; 80(5):754-61. PubMed ID: 18360887
[TBL] [Abstract][Full Text] [Related]
59. Prevalence of Integrase Strand Transfer Inhibitors Resistance Mutations in Integrase Strand Transfer Inhibitors-Naive and -Experienced HIV-1 Infected Patients: A Single Center Experience.
De Francesco MA; Izzo I; Properzi M; Gargiulo F; Caccuri F; Quiros-Roldan E; Castelli F; Caruso A; Focà E
AIDS Res Hum Retroviruses; 2018 Jul; 34(7):570-574. PubMed ID: 29631420
[TBL] [Abstract][Full Text] [Related]
60. Potential drug resistance polymorphisms in the integrase gene of HIV type 1 subtype A.
Herring BL; Cunningham AL; Dwyer DE
AIDS Res Hum Retroviruses; 2004 Sep; 20(9):1010-4. PubMed ID: 15585088
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
